
Solid/Semi-Solid Dosage
Latest News
Latest Videos

Shorts

More News

New manufacturing methods are being explored, but challenges are still present in personalized medicine development.

Rivaroxaban, long known under the brand name Xarelto, is an anticoagulant, a classification that is among the most-prescribed medications in the United States.

The approval makes Evrysdi the first and only tablet for treating spinal muscular atrophy.

Lonza will work with Iconovo to develop spray-dried formulations for an intranasally delivered biologic using a reformulated biologic drug candidate for obesity.

This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.

Through the global partnership, Colorcon will exclusively represent LOTTE’s AnyCoat Hypromellose products.

The ROSS FDA-3500 dual shaft mixer is equipped with independently controlled drives and is designed to efficiently produce good turnover and impart shear to a viscous batch.

The NexGen Press 45 is the latest member of GEA Pharma & Healthcare’s NexGen Press line of tablet presses.

Pelletization, a popular oral drug delivery method in pharmaceuticals and nutraceuticals, offers numerous benefits. This article delves into the critical parameters for formulation development and technological consideration in pelletization, elucidating its significance in advancing pharmaceutical solutions.

Advanced oral dosage forms allow for modulation of controlled- and sustained-release profiles.

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Technical, regulatory, and personnel considerations characterize pharmaceutical compounding.

Matching excipients to API properties is essential.

The acquisition of Qualicaps reflects a strategic investment that aims to strengthen Roquette’s global standing in oral dosage solutions.

Dosage forms are being shaped by numerous factors, with patient-centricity continuing to be an important driver of decisions in development.

The biggest hurdle is developing palatable formulations that are efficacious and patient friendly.












